menu
    • menu

    Company profile for Immunome

    NEW Drugs in Dev: 11
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immunome is developing first-in-class therapeutics to change the way we treat cancer. Our proprietary discovery platform identifies novel therapeutic antibodies, and their targets, by leveraging the “most highly educated” components of the immune systems from patients who have learned to fight off their disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunomeUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    665 Stockton Drive, Suite 300 Exton, PA 19341
    Telephone
    Telephone
    610.321.3700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immunome.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/immunome-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/immunome

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunome Presents Phase 3 RINGSIDE Data for Varegacestat
    Immunome Presents Phase 3 RINGSIDE Data for Varegacestat

    30 May 2026

    // PRESS RELEASE

    https://investors.immunome.com/immunome-announces-detailed-phase-3-ringside-data-for-varegacestat-in-adults-with-progressing-desmoid-tumors-at-the-2026-asco-annual-meeting/

    PRESS RELEASE
    30 May 2026
    Share Share
    Immunome Unveils Q1 2026 Financials And Business Update
    Immunome Unveils Q1 2026 Financials And Business Update

    12 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7424067

    FIRSTWORD PHARMA
    12 May 2026
    Share Share
    Immunome Reports Inducement Grants Under Nasdaq Rule
    Immunome Reports Inducement Grants Under Nasdaq Rule

    05 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-05/immunome-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4

    PHARMIWEB
    05 May 2026
    Share Share
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule

    05 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260505490944/en/Immunome-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    05 May 2026
    Share Share
    Immunome Files FDA NDA for Varegacestat in Desmoid Tumors
    Immunome Files FDA NDA for Varegacestat in Desmoid Tumors

    29 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260429083050/en/Immunome-Announces-Submission-of-New-Drug-Application-to-U.S.-FDA-for-Varegacestat-for-the-Treatment-of-Adults-with-Desmoid-Tumors

    BUSINESSWIRE
    29 Apr 2026
    Share Share
    Immunome Presents Phase 3 RINGSIDE Data At 2026 ASCO Meeting
    Immunome Presents Phase 3 RINGSIDE Data At 2026 ASCO Meeting

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/immunome-announces-oral-presentation-of-phase-3-ringside-data-at-2026-asco-annual-meeting-1

    PHARMIWEB
    21 Apr 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search